RecruitingNCT04507997
Angelman Syndrome Natural History Study
Studying Angelman syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boston Children's Hospital
- Principal Investigator
- Wen-Hann Tan, BMBSBoston Children's Hospital
- Enrollment
- 300 enrolled
- Eligibility
- All sexes
- Timeline
- 2018 – 2031
Study locations (11)
- Cedars-Sinai Guerin Children's, Los Angeles, California, United States
- Rady Children's Hospital, San Diego, San Diego, California, United States
- Children's Hospital Colorado, Anschutz Medical Campus, Aurora, Colorado, United States
- Emory University School of Medicine, Atlanta, Georgia, United States
- Rush University Children's Hospital, Chicago, Illinois, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- The Carolina Institute for Developmental Disabilities, Carrboro, North Carolina, United States
- Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States
- Alberta Children's Hospital, Calgary, Alberta, Canada
- BC Children's Hospital, Vancouver, British Columbia, Canada
- Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada
Collaborators
University of California, San Diego · Angelman Syndrome Biomarker & Outcome Measure Consortium (A-BOM) · Food and Drug Administration (FDA) · Angelman Syndrome Foundation Canada · Foundation for Angelman Syndrome Therapeutics Canada · Foundation for Angelman Syndrome Therapeutics · Angelman Syndrome Foundation, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04507997 on ClinicalTrials.govOther trials for Angelman syndrome
Additional recruiting or active studies for the same condition.